Live Chat

CFD’er er komplekse instrumenter, og der er en stor risiko forbundet med disse for at miste penge på grund af gearing. 74 % af detailinvestorerne har tab på deres konto, når de handler CFD’er med denne udbyder.Du skal overveje, om du forstår, hvordan CFD’er fungerer, og om du har råd til at løbe en stor risiko for at miste dine penge.

Close

Handel Gilead GILD

Sælge
 Køb

Gilead live diagram

5m 15m 30m 1h 4h 1d 1w

Grundlæggende Instrumenter

Weekly Search
Weekly
Daily
Dato Luk Ændring % Ændre Åbn Høj Lav

Info

Spread

0.57

Spread (%)

0.6213 %

Gearing

1:5

Dag til dag-rente Køb

-0.0597 %

Dag til dag-rente Sælg

-0.0292 %

Valuta

USD

Åbningstider for handel

Market lukket

Fredag

14:31 - 20:59

Mandag

14:31-20:59

Tirsdag

14:31-20:59

Onsdag

14:31-20:59

Torsdag

14:31-20:59

Analyse og statistikker

Åbn

---

Forrige luk

---

52 uger høj/lav

--- – ---

Markedsværdi

117585453056

Aktier udestående

1246000000

Indtjeningsdato (Næste)

2013-01-28

Udbytteprocent

2024-09-27

Ex-udbyttedato

2024-12-13

Forventet årlig udbyttesats

3.08

Forventet årlig udbytteprocent

0.0326

EPS

0.09

Få mere at vide om dette instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Relaterede instrumenter

Aktiv
Sælge
Køb
% Ændre

Handl nu

Handl nu

Handl nu

Handl nu
Relaterede instrumenter

Seneste nyheder

Hold dig opdateret med de seneste finansielle nyheder fra hele verden.

Torsdag, 14 November 2024

Dogecoin surges after Elon Musk issues crypto endorsement

Dogecoin surges

Onsdag, 13 November 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Onsdag, 13 November 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Onsdag, 13 November 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Tirsdag, 12 November 2024

UK stock market news: Helium One share price trading 16.1% higher

Tirsdag, 12 November 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

Tirsdag, 12 November 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Tirsdag, 12 November 2024

Dow Jones Dips Ahead of CPI Inflation Data; Tesla shares up

Se alle nyheder
Trustpilot
Live Chat